Michael Bozik
Executive Officer & Director
Contact for company and partnership inquiries through the email provided on this site.
A pharmaceutical startup.
A considered research direction.
Telemachus is a Delaware corporation with a proposed direction that brings therapeutic research and cloud-based analysis of research data into the same conversation.
COMPANY INFORMATIONA clear identity.
A clear identity.
A clear point of contact.
Legal entityTelemachus Therapeutics, Inc.
IncorporationDelaware / 2026
Industry in public filingPharmaceuticals
LocationPennsylvania, United States
SEC company identifierCIK 0002152986
Corporate details are drawn from the SEC Form D record ↗. A securities filing is not scientific validation or endorsement of a product.
Company representatives.
Gregory Hebrank
Executive Officer & Director
Signatory to the September 2, 2026 Form D in the role of Secretary.
OUR PROPOSED DIRECTIONTherapeutic questions.
Therapeutic questions.
Research-data clarity.
The intended approach is to support therapeutic research with well-described datasets, reproducible computational analysis, and thoughtful review of the evidence.
This direction does not establish the stage or performance of a therapeutic program. Program information and the platform vision are described separately so their status remains clear.
SCIENCE / DATA / COLLABORATIONA thoughtful conversation.
Contact Telemachus